{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:49:44Z","timestamp":1789634984621,"version":"4.0.0"},"reference-count":316,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021790","name":"Fondation pour la Recherche sur Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG055865"],"award-info":[{"award-number":["R01AG055865"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG056478"],"award-info":[{"award-number":["R01AG056478"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG075998"],"award-info":[{"award-number":["R01AG075998"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012946","name":"Association Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001961","name":"AXA Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.arr.2022.101819","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T12:30:46Z","timestamp":1670934646000},"page":"101819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer\u2019s disease: relevance for precision medicine in neurodegenerative diseases"],"prefix":"10.1016","volume":"84","author":[{"given":"Simone","family":"Lista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vergallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J.","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Lemercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Sean","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Gabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Garaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola B.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Babiloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhakta Prasad","family":"Gaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Koronyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Koronyo-Hamaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nistic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2022.101819_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/0891988704267463","article-title":"Role of cholinesterase inhibitors in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"17","author":"Aarsland","year":"2004","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000054902","article-title":"Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients","volume":"43","author":"Adler","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.arr.2022.101819_bib3","first-page":"292","article-title":"Prediction of treatment response to rivastigmine in Alzheimer\u2019s dementia","volume":"75","author":"Adler","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/alz.12006","article-title":"Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: What we know, what we don\u2019t, and how to move forward","volume":"16","author":"Alber","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2022.101819_bib5","doi-asserted-by":"crossref","unstructured":"Albin, R.L., van der Zee, S., van Laar, T., Sarter, M., Lustig, C., Muller, M.L.T.M., Bohnen, N.I., 2022, Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson\u2019s disease. pp. 345\u2013371. \u3008https:\/\/doi.org\/10.1016\/bs.pbr.2022.01.011\u3009.","DOI":"10.1016\/bs.pbr.2022.01.011"},{"issue":"Suppl 1","key":"10.1016\/j.arr.2022.101819_bib6","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00002093-200108001-00004","article-title":"Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease","volume":"15","author":"Albuquerque","year":"2001","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/nan.12577","article-title":"Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer\u2019s disease and Lewy body disorders","volume":"46","author":"Alexandris","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2022.101819_bib8","first-page":"16","article-title":"Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy","volume":"149","author":"Alhainen","year":"1993","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.arr.2022.101819_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0304-3940(91)90907-B","article-title":"Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer\u2019s disease","volume":"127","author":"Alhainen","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2022.101819_bib10","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1167\/iovs.12-11481","article-title":"Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma","volume":"54","author":"Almasieh","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.arr.2022.101819_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/gps.4080","article-title":"Efficacy of higher-dose 13.3 mg\/24h (15 cm2) rivastigmine patch on the Alzheimer\u2019s Disease Assessment Scale-cognitive subscale: domain and individual item analysis","volume":"29","author":"Alva","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbi.2010.04.002","article-title":"Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: effects of sex hormone withdrawal","volume":"186","author":"Alves-Amaral","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.arr.2022.101819_bib13","first-page":"15","article-title":"Where dopaminergic and cholinergic systems interact: a gateway for tuning neurodegenerative disorders","author":"Amalric","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib14","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1111\/j.1447-0594.2010.00588.x","article-title":"Acetylcholine-dopamine balance hypothesis in the striatum: An update","volume":"10","author":"Aosaki","year":"2010","journal-title":"Geriatr. Gerontol. Int"},{"key":"10.1016\/j.arr.2022.101819_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneur.59.1.102","article-title":"Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response","volume":"59","author":"Apaydin","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib16","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1167\/iovs.18-25966","article-title":"The Retina in Alzheimer\u2019s Disease: Histomorphometric Analysis of an Ophthalmologic Biomarker","volume":"60","author":"Asanad","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.arr.2022.101819_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/WAD.0b013e31816653bc","article-title":"Long-term course and effectiveness of combination therapy in Alzheimer disease","volume":"22","author":"Atri","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41582-018-0115-7","article-title":"Nature and implications of sex differences in AD pathology","volume":"15","author":"Babapour Mofrad","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib19","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.neuroimage.2006.02.015","article-title":"Donepezil effects on sources of cortical rhythms in mild Alzheimer\u2019s disease: Responders vs. Non-Responders","volume":"31","author":"Babiloni","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2022.101819_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3233\/JAD-2010-1290","article-title":"Global Functional Coupling of Resting EEG Rhythms is Related to White-Matter Lesions Along the Cholinergic Tracts in Subjects with Amnesic Mild Cognitive Impairment","volume":"19","author":"Babiloni","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2022.101819_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clinph.2019.06.234","article-title":"International Federation of Clinical Neurophysiology (IFCN) \u2013 EEG research workgroup: Recommendations on frequency and topographic analysis of resting state EEG rhythms. Part 1: Applications in clinical research studies","volume":"131","author":"Babiloni","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.arr.2022.101819_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neurobiolaging.2019.09.008","article-title":"What electrophysiology tells us about Alzheimer\u2019s disease: a window into the synchronization and connectivity of brain neurons","volume":"85","author":"Babiloni","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2022.101819_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-143096","article-title":"Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer\u2019s Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1","volume":"46","author":"Bacchetti","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101819_bib24","first-page":"164","article-title":"Effect of donepezil on EEG spectral analysis in Alzheimer\u2019s disease","volume":"103","author":"Balkan","year":"2003","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.arr.2022.101819_bib25","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1212\/01.wnl.0000261920.03297.64","article-title":"Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies","volume":"68","author":"Ballard","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101819_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","article-title":"Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline","volume":"91","author":"Ballinger","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2022.101819_bib27","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.neurobiolaging.2007.11.003","article-title":"APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer\u2019s disease","volume":"30","author":"Barabash","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2022.101819_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jgs.16182","article-title":"Development and Validation of eRADAR: A Tool Using EHR Data to Detect Unrecognized Dementia","volume":"68","author":"Barnes","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2022.101819_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s004010050595","article-title":"Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer\u2019s disease","volume":"93","author":"Beach","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101819_bib30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnen\/59.4.308","article-title":"The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease","volume":"59","author":"Beach","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Suppl D","key":"10.1016\/j.arr.2022.101819_bib31","first-page":"113","article-title":"Cholinergic function and dysfunction in the visual system","volume":"24","author":"Beelke","year":"2002","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/brain\/awm299","article-title":"Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer\u2019s disease and health","volume":"131","author":"Bentley","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1037\/0735-7044.109.5.859","article-title":"Sex differences in learning and memory in mice: effects of sequence of testing and cholinergic blockade","volume":"109","author":"Berger-Sweeney","year":"1995","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3233\/JAD-140969","article-title":"Repetitive pupil light reflex: potential marker in Alzheimer\u2019s disease?","volume":"42","author":"Bittner","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101819_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000087371","article-title":"Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer\u2019s disease","volume":"20","author":"Bizzarro","year":"2005","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib36","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","article-title":"Cholinergic system changes in Parkinson\u2019s disease: emerging therapeutic approaches","volume":"21","author":"Bohnen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JCP.0b013e31819a8f2e","article-title":"Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study","volume":"29","author":"Bokde","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pscychresns.2016.01.018","article-title":"Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study","volume":"249","author":"Bokde","year":"2016","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.arr.2022.101819_bib40","first-page":"16","article-title":"The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\u2019s disease (review of Technology Appraisal No. 111): a systematic review and economic model","author":"Bond","year":"2012","journal-title":"Health Technol. Assess. (Rockv. )"},{"key":"10.1016\/j.arr.2022.101819_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/nan.12534","article-title":"Review: Molecular pathology of frontotemporal lobar degenerations","volume":"45","author":"Borroni","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2022.101819_bib42","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1523\/JNEUROSCI.1174-16.2016","article-title":"APOE-Sensitive Cholinergic Sprouting Compensates for Hippocampal Dysfunctions Due to Reduced Entorhinal Input","volume":"36","author":"Bott","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbr.2015.06.037","article-title":"Donepezil increases contrast sensitivity for the detection of objects in scenes","volume":"292","author":"Boucart","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2022.101819_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2022.101819_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.arr.2022.101819_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1533317514539540","article-title":"Effect of APOE and CHRNA7 genotypes on the cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer\u2019s disease","volume":"30","author":"Braga","year":"2015","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.arr.2022.101819_bib47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-2003-45118","article-title":"Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial","volume":"36","author":"Brassen","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JAD-150063","article-title":"Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer\u2019s Disease in Patients with Mild Cognitive Impairment \u2013 A Multicenter DTI and Volumetry Study","volume":"48","author":"Brueggen","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2022.101819_bib49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.phrs.2016.11.035","article-title":"Sex and gender differences in the treatment of Alzheimer\u2019s disease: A systematic review of randomized controlled trials","volume":"115","author":"Canevelli","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2022.101819_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jmg.2007.052704","article-title":"Alpha7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer\u2019s disease","volume":"45","author":"Carson","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.arr.2022.101819_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect","volume":"361","author":"Caselli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2022.101819_bib53","doi-asserted-by":"crossref","first-page":"e1631","DOI":"10.4088\/JCP.15m10413","article-title":"Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer\u2019s Disease","volume":"77","author":"Cavedo","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib54","doi-asserted-by":"crossref","first-page":"11706","DOI":"10.1038\/s41598-017-09780-3","article-title":"Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer\u2019s disease","volume":"7","author":"Cavedo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101819_bib55","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jalz.2018.05.014","article-title":"Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer\u2019s disease in cognitively normal older adults with subjective memory complaints","volume":"14","author":"Cavedo","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2022.101819_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fnins.2020.00161","article-title":"Evidence of Synaptic and Neurochemical Remodeling in the Retina of Aging Degus","volume":"14","author":"Chang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jmri.23967","article-title":"Hemodynamic effects of cholinesterase inhibition in mild Alzheimer\u2019s disease","volume":"38","author":"Chaudhary","year":"2013","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.arr.2022.101819_bib58","first-page":"13","article-title":"Exploring the pathogenesis of Alzheimer disease in basal forebrain cholinergic neurons: converging insights from alternative hypotheses","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000124752","article-title":"Effect of ApoE genotype on response to donepezil in patients with Alzheimer\u2019s disease","volume":"25","author":"Choi","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fnagi.2015.00130","article-title":"Menopause, obesity and inflammation: interactive risk factors for Alzheimer\u2019s disease","volume":"7","author":"Christensen","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib61","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/mp.2016.214","article-title":"Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3\u03b2 kinase: implications for Alzheimer\u2019s disease","volume":"22","author":"Chu","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mcn.2011.04.008","article-title":"ERK1-independent \u03b1-secretase cut of \u03b2-amyloid precursor protein via M1 muscarinic receptors and PKC\u03b1\/\u03b5","volume":"47","author":"Cisse","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib63","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3233\/JAD-160074","article-title":"CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer\u2019s Disease Patients","volume":"52","author":"Clarelli","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101819_bib64","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1073\/pnas.85.4.1227","article-title":"In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease","volume":"85","author":"Cohen","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.arr.2022.101819_bib65","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.arr.2022.101819_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jchemneu.2011.02.004","article-title":"Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer\u2019s disease","volume":"42","author":"Counts","year":"2011","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.arr.2022.101819_bib67","first-page":"13","article-title":"Editorial: The Involvement of NGF in the Alzheimer\u2019s Pathology","author":"Cuello","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JAD-131190","article-title":"Differential Effects of Current Specific Treatments on Behavioral and Psychological Symptoms in Patients with Alzheimer\u2019s Disease: A 12-Month, Randomized, Open-Label Trial","volume":"39","author":"Cumbo","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2022.101819_bib69","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","article-title":"Cholinergic markers in elderly patients with early signs of Alzheimer disease","volume":"281","author":"Davis","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2022.101819_bib70","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1080\/14656566.2016.1215431","article-title":"Pharmacotherapeutic strategies in the treatment of severe Alzheimer\u2019s disease","volume":"17","author":"Deardorff","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.arr.2022.101819_bib71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib72","unstructured":"AlzGene, n.d. AlzGene - Field synopsis of genetic association studies in AD [WWW Document]. URL \u3008http:\/\/www.alzgene.org\/\u3009 (accessed 10.31.21)."},{"key":"10.1016\/j.arr.2022.101819_bib73","unstructured":"DeSarno, P., Giacobini, E., McIlhany, M. et al., 1988, Nicotinic receptors in human CNS: a biopsy study, in: Eurotext, J.L. (Ed.), Agnoli A, 2nd Int Symp on Senile Dementias Montrouge. pp. 329\u201334."},{"key":"10.1016\/j.arr.2022.101819_bib74","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.23789","article-title":"Auditory cortical function during verbal episodic memory encoding in Alzheimer\u2019s disease","volume":"73","author":"Dhanjal","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt25","article-title":"Predicting progression of Alzheimer\u2019s disease","volume":"2","author":"Doody","year":"2010","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13195-018-0457-9","article-title":"Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a network meta-analysis of 41 randomized controlled trials","volume":"10","author":"Dou","year":"2018","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2022.101819_bib77","article-title":"Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid \u03b2-protein and phosphorylated tau","author":"Du","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.arr.2022.101819_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-9-3","article-title":"Stem cell derived basal forebrain cholinergic neurons from Alzheimer\u2019s disease patients are more susceptible to cell death","volume":"9","author":"Duan","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2022.101819_bib79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jnen\/63.2.159","article-title":"ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus","volume":"63","author":"Dubelaar","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib80","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.25098","article-title":"Donepezil in Parkinson\u2019s disease dementia: a randomized, double-blind efficacy and safety study","volume":"27","author":"Dubois","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib81","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jalz.2014.10.003","article-title":"Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer\u2019s disease","volume":"11","author":"Dubois","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2022.101819_bib82","first-page":"10","article-title":"Retinal venular tortuosity jointly with retinal amyloid burden correlates with verbal memory loss: a pilot study","author":"Dumitrascu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.arr.2022.101819_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116781","article-title":"Region-specific sex differences in the hippocampus","volume":"215","author":"van Eijk","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2022.101819_bib84","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson\u2019s disease","volume":"351","author":"Emre","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2022.101819_bib85","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1179\/01610425017631","article-title":"Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors","volume":"26","author":"Erkinjuntti","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.arr.2022.101819_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108442","article-title":"Intravitreal Interleukin-2 modifies retinal excitatory circuits and retinocollicular innervation","volume":"204","author":"Esp\u00edrito-Santo","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.arr.2022.101819_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.06.003","article-title":"Cholinergic nervous system and glaucoma: From basic science to clinical applications","volume":"72","author":"Faiq","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.arr.2022.101819_bib88","first-page":"332","article-title":"Differential qualitative responses to rivastigmine in APOE epsilon 4 carriers and noncarriers","volume":"4","author":"Farlow","year":"2004","journal-title":"Pharm. J."},{"key":"10.1016\/j.arr.2022.101819_bib89","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1533317510365344","article-title":"Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer\u2019s disease","volume":"25","author":"Farlow","year":"2010","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.arr.2022.101819_bib90","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/gps.2141","article-title":"Treatment with galantamine and time to nursing home placement in Alzheimer\u2019s disease patients with and without cerebrovascular disease","volume":"24","author":"Feldman","year":"2009","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib91","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/brain\/awaa012","article-title":"Basal forebrain volume reliably predicts the cortical spread of Alzheimer\u2019s degeneration","volume":"143","author":"Fern\u00e1ndez-Cabello","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib92","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease - the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib93","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.genm.2009.06.004","article-title":"Effects of gender on response to treatment with rivastigmine in mild cognitive impairment: A post hoc statistical modeling approach","volume":"6","author":"Ferris","year":"2009","journal-title":"Gend. Med."},{"key":"10.1016\/j.arr.2022.101819_bib94","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000440864","article-title":"AF710B, a Novel M1\/\u03c31 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer\u2019s Disease","volume":"16","author":"Fisher","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2022.101819_bib95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib96","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bph.12362","article-title":"Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women","volume":"171","author":"Franconi","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib97","doi-asserted-by":"crossref","first-page":"7935406","DOI":"10.1155\/2017\/7935406","article-title":"Evaluation of Cholinergic Deficiency in Preclinical Alzheimer\u2019s Disease Using Pupillometry","volume":"2017","author":"Frost","year":"2017","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.arr.2022.101819_bib98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/gim.2016.80","article-title":"Prediction of CYP2D6 phenotype from genotype across world populations","volume":"19","author":"Gaedigk","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.arr.2022.101819_bib99","first-page":"13","article-title":"The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain","author":"Gasiorowska","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2012.12.001","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease: Past progress and anticipation of the future","volume":"9","author":"Geda","year":"2013","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2022.101819_bib101","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jalz.2017.08.011","article-title":"Knowledge-driven computational modeling in Alzheimer\u2019s disease research: Current state and future trends","volume":"13","author":"Geerts","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2022.101819_bib102","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2017.05.062","article-title":"Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer\u2019s disease","volume":"817","author":"Geerts","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib103","series-title":"Alzheimer Disease","first-page":"269","article-title":"Cholinergic systems in Alzheimer\u2019s disease","author":"Geula","year":"1999"},{"key":"10.1016\/j.arr.2022.101819_bib104","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0079-6123(08)60916-4","article-title":"The cholinergic system in Alzheimer disease","volume":"84","author":"Giacobini","year":"1990","journal-title":"Prog. Brain Res"},{"key":"10.1016\/j.arr.2022.101819_bib105","doi-asserted-by":"crossref","first-page":"412A","DOI":"10.1097\/00002826-199201001-00215","article-title":"Pharmacological replacement of cholinergic function in Alzheimer disease","volume":"15","author":"Giacobini","year":"1992","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib106","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awac096","article-title":"Reimagining cholinergic therapy for Alzheimer\u2019s disease","author":"Giacobini","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib107","article-title":"Neuropathological correlates of neuropsychiatric symptoms in dementia","author":"Gibson","year":"2022","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.arr.2022.101819_bib108","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jalz.2011.02.009","article-title":"Long-term progression of Alzheimer\u2019s disease in patients under antidementia drugs","volume":"7","author":"Gillette-Guyonnet","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2022.101819_bib109","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.neuroimage.2004.08.006","article-title":"Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study","volume":"23","author":"Goekoop","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2022.101819_bib110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/brain\/awh671","article-title":"Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study","volume":"129","author":"Goekoop","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib111","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jmri.22662","article-title":"Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer\u2019s disease patients treated with donepezil assessed by resting-state fMRI","volume":"34","author":"Goveas","year":"2011","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.arr.2022.101819_bib112","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/1099-1166(200011)15:11<1028::AID-GPS227>3.0.CO;2-E","article-title":"A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer\u2019s disease","volume":"15","author":"Grace","year":"2000","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib113","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0167-8760(02)00122-8","article-title":"Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"47","author":"Granholm","year":"2003","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.arr.2022.101819_bib114","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneur.57.1.94","article-title":"Donepezil therapy in clinical practice: a randomized crossover study","volume":"57","author":"Greenberg","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib115","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1533317510385808","article-title":"Reviews: Effects of Transdermal Rivastigmine on ADAS-Cog Items in Mild-to-Moderate Alzheimer\u2019s Disease","volume":"25","author":"Grossberg","year":"2010","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"10.1016\/j.arr.2022.101819_bib116","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cercor\/bhp232","article-title":"Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer\u2019s disease","volume":"20","author":"Grothe","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.arr.2022.101819_bib117","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1016\/j.jalz.2013.09.011","article-title":"Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects","volume":"10","author":"Grothe","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2022.101819_bib118","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/cercor\/bhv062","article-title":"Cognitive correlates of basal forebrain atrophy and associated cortical hypometabolism in mild cognitive impairment","volume":"26","author":"Grothe","year":"2016","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.arr.2022.101819_bib119","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/brain\/aww003","article-title":"Network-selective vulnerability of the human cerebellum to Alzheimer\u2019s disease and frontotemporal dementia","volume":"139","author":"Guo","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.31887\/DCNS.2002.4.2\/rgur","article-title":"Gender differences in aging: cognition, emotions, and neuroimaging studies","volume":"4","author":"Gur","year":"2002","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib121","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1212\/WNL.0000000000006116","article-title":"White matter lesions: Spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy","volume":"91","author":"Habes","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101819_bib122","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2017.01.019","article-title":"The ventral hippocampal muscarinic cholinergic system plays a key role in sexual dimorphisms of spatial working memory in rats","volume":"117","author":"Hall","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2022.101819_bib123","first-page":"12","article-title":"P4\u2013013: Pro\u2010Cognitive and Anti\u2010Inflammatory Effects of Af710B, a Mixed M1 Muscarinic\/Sigma\u20101 Receptor Agonist, in the Mcgill\u2010R\u2010Thy1\u2013App Rat Model of Human Ad\u2010Like Amyloid Pathology","author":"Hall","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2022.101819_bib124","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101662","article-title":"Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer\u2019s disease","volume":"181","author":"Hampel","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2022.101819_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","author":"Hampel","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib127","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","article-title":"Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease","volume":"77","author":"Hanna Al-Shaikh","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib129","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.arr.2022.101819_bib130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.fpc.0000189799.88596.04","article-title":"A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"16","author":"Harold","year":"2006","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.arr.2022.101819_bib131","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer\u2019s: exploring disease in the retina","volume":"132","author":"Hart","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101819_bib132","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s11030-021-10245-z","article-title":"Machine learning models to select potential inhibitors of acetylcholinesterase activity from SistematX: a natural products database","volume":"25","author":"Herrera-Acevedo","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.arr.2022.101819_bib133","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00019442-200506000-00012","article-title":"Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials","volume":"13","author":"Herrmann","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib134","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamaneurol.2018.0821","article-title":"Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau","volume":"75","author":"Hohman","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuroimage.2017.07.030","article-title":"FGWAS: Functional genome wide association analysis","volume":"159","author":"Huang","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2022.101819_bib136","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-014-0083-0","article-title":"Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial","volume":"7","author":"Ikeda","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib137","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.64.9.1312","article-title":"Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease","volume":"64","author":"Ikonomovic","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib138","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.bbadis.2015.10.023","article-title":"Attenuation of functional hyperemia to visual stimulation in mild Alzheimer\u2019s disease and its sensitivity to cholinesterase inhibition","volume":"1862","author":"Janik","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2022.101819_bib139","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneurol.2015.237","article-title":"Donepezil and nursing home placement \u2014 benefits and costs","volume":"12","author":"Jelic","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-006-0447-7","article-title":"PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer\u2019s disease","volume":"188","author":"Kadir","year":"2006","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.arr.2022.101819_bib141","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s00018-016-2175-4","article-title":"Modulatory effects of \u03b17 nAChRs on the immune system and its relevance for CNS disorders","volume":"73","author":"Kalkman","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.arr.2022.101819_bib142","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nicl.2014.11.015","article-title":"Basal forebrain atrophy correlates with amyloid \u03b2 burden in Alzheimer\u2019s disease","volume":"7","author":"Kerbler","year":"2015","journal-title":"NeuroImage. Clin."},{"key":"10.1016\/j.arr.2022.101819_bib143","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1111\/bph.14030","article-title":"Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer\u2019s disease","volume":"174","author":"Kim","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib144","first-page":"1006","article-title":"Cortical activation during cholinesterase-inhibitor treatment in Alzheimer disease: preliminary findings from a pharmaco-fMRI study","volume":"13","author":"Kircher","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroimage.2019.05.044","article-title":"Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer\u2019s disease","volume":"199","author":"Klaassens","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2022.101819_bib146","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1038\/npp.2014.119","article-title":"Dopaminergic Modulation of Cortical Plasticity in Alzheimer\u2019s Disease Patients","volume":"39","author":"Koch","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.arr.2022.101819_bib147","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s007020170006","article-title":"EEG changes during long-term treatment with donepezil in Alzheimer\u2019s disease patients","volume":"108","author":"Kogan","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2022.101819_bib148","first-page":"203","article-title":"Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer\u2019s disease","author":"Kogan","year":"2007","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.arr.2022.101819_bib149","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41398-020-01129-1","article-title":"Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19","volume":"11","author":"Koopmans","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000335154","article-title":"Alzheimer\u2019s disease in the retina: imaging retinal a\u03b2 plaques for early diagnosis and therapy assessment","volume":"10","author":"Koronyo","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2022.101819_bib151","first-page":"2","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease","author":"Koronyo","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.arr.2022.101819_bib152","first-page":"1452","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013"},{"key":"10.1016\/j.arr.2022.101819_bib153","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.trci.2017.07.001","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: New treatment paradigms","volume":"3","author":"Lanct\u00f4t","year":"2017","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2022.101819_bib154","doi-asserted-by":"crossref","first-page":"168","DOI":"10.9758\/cpn.2015.13.2.168","article-title":"The Effect of Choline Acetyltransferase Genotype on Donepezil Treatment Response in Patients with Alzheimer\u2019s Disease","volume":"13","author":"Lee","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib155","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2967\/jnumed.108.054668","article-title":"Changes in cerebral glucose metabolism in patients with Parkinson disease with dementia after cholinesterase inhibitor therapy","volume":"49","author":"Lee","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2022.101819_bib156","first-page":"507","article-title":"Dementia: the University of Oklahoma autopsy experience","volume":"94","author":"Leech","year":"2001","journal-title":"J. Okla. State Med. Assoc."},{"key":"10.1016\/j.arr.2022.101819_bib157","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/387073a0","article-title":"Contrast dependence of contextual effects in primate visual cortex","volume":"387","author":"Levitt","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.arr.2022.101819_bib158","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.neuroimage.2011.12.077","article-title":"Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer\u2019s disease after 12-week donepezil treatment","volume":"60","author":"Li","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2022.101819_bib159","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-0716-2213-1_6","article-title":"Acetylcholinesterase Inhibition Assays for High-Throughput Screening","volume":"2474","author":"Li","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.arr.2022.101819_bib160","first-page":"CD009444","article-title":"Cholinesterase inhibitors for rarer dementias associated with neurological conditions","author":"Li","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.arr.2022.101819_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2022.08.025","article-title":"Molecularly defined and functionally distinct cholinergic subnetworks","author":"Li","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2022.101819_bib162","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"129","author":"Liu","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101819_bib163","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib164","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-022-02250-2","article-title":"Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model","volume":"20","author":"Liu","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.arr.2022.101819_bib165","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/s41598-018-38239-2","article-title":"Novel findings from 2,838 Adult Brains on Sex Differences in Gray Matter Brain Volume","volume":"9","author":"Lotze","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101819_bib166","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2015.12.062","article-title":"The roles of apolipoprotein E3 and CYP2D6 (rs1065852) gene polymorphisms in the predictability of responses to individualized therapy with donepezil in Han Chinese patients with Alzheimer\u2019s disease","volume":"614","author":"Lu","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2022.101819_bib167","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fphar.2020.00934","article-title":"Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy","volume":"11","author":"Lu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib168","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2022.101819_bib169","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-020-00620-7","article-title":"The cholinergic system in subtypes of Alzheimer\u2019s disease: an in vivo longitudinal MRI study","volume":"12","author":"Machado","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S1041610201007670","article-title":"Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep","volume":"13","author":"Maclean","year":"2001","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.arr.2022.101819_bib171","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neurobiolaging.2017.08.001","article-title":"Differential vulnerability of hippocampal subfields and anteroposterior hippocampal subregions in healthy cognitive aging","volume":"59","author":"Malykhin","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2022.101819_bib172","first-page":"430","article-title":"National patterns of dementia treatment among elderly ambulatory patients","volume":"98","author":"Maneno","year":"2006","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.arr.2022.101819_bib173","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"\u201cIs dopamine involved in Alzheimer\u2019s disease?\u201d","volume":"6","author":"Martorana","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib174","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/156720510791383877","article-title":"Established donepezil treatment modulates task relevant regional brain activation in early Alzheimer\u2019s disease","volume":"7","author":"McGeown","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2022.101819_bib175","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.arr.2022.101819_bib176","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000335876","article-title":"Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer\u2019s disease","volume":"9","author":"McLaren","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2022.101819_bib177","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1186\/s12864-020-07282-7","article-title":"Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer\u2019s disease","volume":"21","author":"Meng","year":"2020","journal-title":"BMC Genom."},{"key":"10.1016\/j.arr.2022.101819_bib178","first-page":"15","article-title":"Long-Term Depression of Striatal DA Release Induced by mGluRs via Sustained Hyperactivity of Local Cholinergic Interneurons","author":"Mercuri","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib179","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.biopsych.2012.02.025","article-title":"Cholinergic Aspects of Aging and Alzheimer\u2019s Disease","volume":"71","author":"Mesulam","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib180","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.20100","article-title":"Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum","volume":"55","author":"Mesulam","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib181","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1002\/cne.23415","article-title":"Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer\u2019s disease","volume":"521","author":"Mesulam","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib182","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/156720511797633241","article-title":"Effect of cholinergic stimulation in early Alzheimer\u2019s disease - functional imaging during a recognition memory task","volume":"8","author":"Miettinen","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2022.101819_bib183","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/alz.12358","article-title":"Diagnostic criteria for apathy in neurocognitive disorders","volume":"17","author":"Miller","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2022.101819_bib184","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3233\/JAD-142148","article-title":"Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer\u2019s disease and mixed dementia: a one-year naturalistic study","volume":"45","author":"Miranda","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101819_bib185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3389\/fnins.2020.00921","article-title":"Alzheimer\u2019s Retinopathy: Seeing Disease in the Eyes","volume":"14","author":"Mirzaei","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib186","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/7854_2010_95","article-title":"Sex differences in the septo-hippocampal cholinergic system in rats: behavioral consequences.","volume":"8","author":"Mitsushima","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib187","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jalz.2012.04.006","article-title":"Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort","volume":"8","author":"Moghekar","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2022.101819_bib188","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2022.101819_bib189","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-014-0081-2","article-title":"Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial","volume":"7","author":"Mori","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.105.087908","article-title":"Modulation of N -Methyl-d-aspartate Receptors by Donepezil in Rat Cortical Neurons","volume":"315","author":"Moriguchi","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib191","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0014-4835(03)00050-2","article-title":"Corneal nerves: structure, contents and function","volume":"76","author":"M\u00fcller","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.arr.2022.101819_bib192","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/14656566.2022.2042514","article-title":"Pharmacotherapeutic combinations for the treatment of Alzheimer\u2019s disease","volume":"23","author":"Nagata","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.arr.2022.101819_bib193","article-title":"A phase 1b\/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer\u2019s disease","volume":"8","author":"Nathan","year":"2022","journal-title":"Alzheimer\u2019s Dement. (N. Y., N. Y. )"},{"key":"10.1016\/j.arr.2022.101819_bib194","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1038\/s41598-021-91391-0","article-title":"Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical data","volume":"11","author":"Nazmuddin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101819_bib195","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116607","article-title":"Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert","volume":"211","author":"Nemy","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2022.101819_bib197","article-title":"Cholinergic white matter pathways along the Alzheimer\u2019s disease continuum","author":"Nemy","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib198","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.1411529","article-title":"Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors","volume":"258","author":"Nitsch","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.arr.2022.101819_bib199","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2022.101819_bib200","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S1388-2457(02)00110-4","article-title":"Effects of long-term Donepezil therapy on rCBF of Alzheimer\u2019s patients","volume":"113","author":"Nobili","year":"2002","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.arr.2022.101819_bib201","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pscychresns.2014.11.011","article-title":"Intracranial volume normalization methods: Considerations when investigating gender differences in regional brain volume","volume":"231","author":"Nordenskj\u00f6ld","year":"2015","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.arr.2022.101819_bib202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00008571-200304000-00008","article-title":"Regulation of attention and response to therapy in dementia by butyrylcholinesterase","volume":"13","author":"O\u2019Brien","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.arr.2022.101819_bib203","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1073\/pnas.0408500102","article-title":"Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer\u2019s disease","volume":"102","author":"Oddo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.arr.2022.101819_bib204","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0013-7006(07)91552-3","article-title":"[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease]","volume":"33","author":"Ollat","year":"2007","journal-title":"Encephale"},{"key":"10.1016\/j.arr.2022.101819_bib205","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.2147\/DDDT.S247259","article-title":"Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil","volume":"14","author":"Ortner","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib206","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fphar.2020.00691","article-title":"Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer\u2019s Dementia Are Frequently Below the Recommended Levels","volume":"11","author":"Ortner","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib207","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tics.2018.12.006","article-title":"Dopamine and Cognitive Control in Prefrontal Cortex","volume":"23","author":"Ott","year":"2019","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.arr.2022.101819_bib208","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0197-0186(00)00091-7","article-title":"Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro","volume":"38","author":"Pakaski","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2022.101819_bib209","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bcp.2011.06.039","article-title":"Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer\u2019s disease","volume":"82","author":"Parri","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib210","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s00213-021-05923-7","article-title":"Functional connectivity and cognitive changes after donepezil treatment in healthy participants","volume":"238","author":"P\u00e9ran","year":"2021","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.arr.2022.101819_bib211","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","article-title":"Cholinergic correlates of cognitive impairment in Parkinson\u2019s disease: comparisons with Alzheimer\u2019s disease","volume":"48","author":"Perry","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib212","first-page":"131","article-title":"Cortical neuropathological and neurochemical substrates of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"24","author":"Perry","year":"1987","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.arr.2022.101819_bib213","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101819_bib214","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3174\/ajnr.A1359","article-title":"Effects of Donepezil on Cortical Activation in Mild Cognitive Impairment: A Pilot Double-Blind Placebo-Controlled Trial Using Functional MR Imaging","volume":"30","author":"Petrella","year":"2009","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.arr.2022.101819_bib215","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S1388-2457(99)00141-8","article-title":"Event-related EEG\/MEG synchronization and desynchronization: basic principles","volume":"110","author":"Pfurtscheller","year":"1999","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.arr.2022.101819_bib216","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1212\/WNL.0b013e3181b6bbe3","article-title":"Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease","volume":"73","author":"Pilotto","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101819_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2011.01.003","article-title":"Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer\u2019s type","author":"Pinto","year":"2011","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2022.101819_bib218","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41598-018-19154-y","article-title":"Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer\u2019s disease at various cognitive stages","volume":"8","author":"Poirel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101819_bib219","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer\u2019s disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.arr.2022.101819_bib220","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neulet.2005.03.027","article-title":"Responsiveness to cholinesterase inhibitors in Alzheimer\u2019s disease: A possible role for the 192 Q\/R polymorphism of the PON-1 gene","volume":"382","author":"Pola","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2022.101819_bib221","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/mds.25575","article-title":"Rivastigmine is associated with restoration of left frontal brain activity in Parkinson\u2019s disease","volume":"28","author":"Possin","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib222","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-011-0831-1","article-title":"Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer\u2019s disease","volume":"122","author":"Potter","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101819_bib223","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2165\/11631830-000000000-00000","article-title":"Economic Evaluation of Treatment Options in Patients with Alzheimer\u02bcs Disease","volume":"72","author":"Pouryamout","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.arr.2022.101819_bib224","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jnnp.62.6.665","article-title":"Altered pupillary size and darkness and light reflexes in Alzheimer\u2019s disease","volume":"62","author":"Prettyman","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib225","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib226","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1007\/s00213-014-3533-2","article-title":"Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPET","volume":"231","author":"Ramakrishnan","year":"2014","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.arr.2022.101819_bib227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41398-020-0709-x","article-title":"Rivastigmine modifies the \u03b1-secretase pathway and potentially early Alzheimer\u2019s disease","volume":"10","author":"Ray","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib228","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1523\/JNEUROSCI.3617-14.2015","article-title":"Cholinergic basal forebrain structure influences the reconfiguration of white matter connections to support residual memory in mild cognitive impairment","volume":"35","author":"Ray","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib229","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/brain\/awx310","article-title":"In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease","volume":"141","author":"Ray","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib230","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1523\/JNEUROSCI.1388-17.2017","article-title":"Amyloid and tau pathology in normal cognitive aging","volume":"37","author":"Reas","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib231","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264074","article-title":"The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer\u2019s disease targeting acetylcholinesterase","volume":"17","author":"Rehman","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2022.101819_bib232","first-page":"11","article-title":"Paraoxonase role in human neurodegenerative diseases","volume":"10","author":"Reichert","year":"2020","journal-title":"Antioxid. (Basel, Switz. )"},{"key":"10.1016\/j.arr.2022.101819_bib233","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-0173(99)00011-9","article-title":"Functional sex differences ('sexual diergism\u2019) of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review","volume":"30","author":"Rhodes","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.arr.2022.101819_bib234","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41593-019-0520-2","article-title":"A deep learning framework for neuroscience","volume":"22","author":"Richards","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib235","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/brain\/awx356","article-title":"Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer\u2019s disease","volume":"141","author":"Richter","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib236","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1017\/S0317167100014670","article-title":"Cognitive Change in Donepezil Treated Patients with Vascular or Mixed Dementia","volume":"40","author":"Rockwood","year":"2013","journal-title":"Can. J. Neurol. Sci. \/ J. Can. Des. Sci. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib237","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1388-2457(03)00321-3","article-title":"Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer\u2019s disease","volume":"115","author":"Rodriguez","year":"2004","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.arr.2022.101819_bib238","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.neurobiolaging.2005.10.004","article-title":"Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia","volume":"27","author":"Rom\u00e1n","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2022.101819_bib239","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jnnp.73.6.665","article-title":"Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer\u2019s disease","volume":"73","author":"Rombouts","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib240","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.clinph.2020.03.003","article-title":"Early diagnosis of Alzheimer\u2019s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts","volume":"131","author":"Rossini","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.arr.2022.101819_bib241","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1533317506297517","article-title":"Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer\u2019s disease: a case control study","volume":"22","author":"Rozzini","year":"2007","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.arr.2022.101819_bib242","first-page":"CD009132","article-title":"Cholinesterase inhibitors for mild cognitive impairment","author":"Russ","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.arr.2022.101819_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105514","article-title":"A single-molecule with multiple investigations: Synthesis, characterization, computational methods, inhibitory activity against Alzheimer\u2019s disease, toxicity, and ADME studies","volume":"146","author":"\u015eahin","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.arr.2022.101819_bib244","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/neup.12581","article-title":"Delusions and visual hallucinations in a patient with Parkinson\u2019s disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert","volume":"39","author":"Sakai","year":"2019","journal-title":"Neuropathology"},{"key":"10.1016\/j.arr.2022.101819_bib245","first-page":"339","article-title":"Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer\u2019s Disease","volume":"10","author":"Salazar","year":"2021","journal-title":"Antioxid. (Basel, Switz. )"},{"key":"10.1016\/j.arr.2022.101819_bib246","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.95.19.11445","article-title":"Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer\u2019s disease is apolipoprotein E-type dependent","volume":"95","author":"Salehi","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2022.101819_bib247","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S1041610207005650","article-title":"Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI","volume":"20","author":"Salloway","year":"2008","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.arr.2022.101819_bib248","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3233\/JAD-200043","article-title":"Neuro-Retina Might Reflect Alzheimer\u2019s Disease Stage.","volume":"77","author":"Santangelo","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101819_bib249","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000102569","article-title":"Cognitive predictors of donepezil therapy response in Alzheimer disease","volume":"24","author":"Saumier","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib250","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/brain\/awh177","article-title":"Cholinergic enhancement of frontal lobe activity in mild cognitive impairment","volume":"127","author":"Saykin","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib251","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajmg.b.30846","article-title":"Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer\u2019s disease and relationships with response to treatment with Donepezil and Rivastigmine","volume":"150B","author":"Scacchi","year":"2009","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"key":"10.1016\/j.arr.2022.101819_bib252","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/gps.4043","article-title":"Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer\u2019s disease","volume":"29","author":"Scacchi","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib253","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1038\/ncomms13249","article-title":"Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer\u2019s pathology","volume":"7","author":"Schmitz","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2022.101819_bib254","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/brain\/awy072","article-title":"Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease","volume":"141","author":"Schulz","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib255","article-title":"Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer\u2019s disease","author":"Schumacher","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101819_bib256","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102604","article-title":"In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies","volume":"30","author":"Schumacher","year":"2021","journal-title":"NeuroImage. Clin."},{"key":"10.1016\/j.arr.2022.101819_bib257","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.7973660","article-title":"A potential noninvasive neurobiological test for Alzheimer\u2019s disease","volume":"266","author":"Scinto","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.arr.2022.101819_bib258","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.mri.2007.02.005","article-title":"Regional brain activity after prolonged cholinergic enhancement in early Alzheimer\u2019s disease","volume":"25","author":"Shanks","year":"2007","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.arr.2022.101819_bib259","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1476-5381.2010.00894.x","article-title":"Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors","volume":"161","author":"Shen","year":"2010","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.arr.2022.101819_bib260","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s40478-020-01076-4","article-title":"Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer\u2019s disease","volume":"8","author":"Shi","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2022.101819_bib261","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00401-020-02134-w","article-title":"Identification of early pericyte loss and vascular amyloidosis in Alzheimer\u2019s disease retina","volume":"139","author":"Shi","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101819_bib262","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.731614","article-title":"Retinal Vasculopathy in Alzheimer\u2019s Disease","volume":"15","author":"Shi","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib263","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40478-022-01439-z","article-title":"Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer\u2019s-induced retinal vasculopathy by limiting Clec7a\/Galectin-3+ neurodegenerative microglia","volume":"10","author":"Shi","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2022.101819_bib264","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.arr.2022.101819_bib265","first-page":"58","article-title":"EEG regional changes during long-term treatment with tetrahydroaminoacridine (THA) in Alzheimer\u2019s disease","volume":"149","author":"Shigeta","year":"1993","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.arr.2022.101819_bib266","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1051228405001468","article-title":"SPECT Follow-Up Study of Cerebral Blood Flow Changes During Donepezil Therapy in Patients with Alzheimer\u2019s Disease","volume":"16","author":"Shimizu","year":"2006","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.arr.2022.101819_bib267","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-62703-321-3_21","article-title":"Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database","volume":"987","author":"Sim","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.arr.2022.101819_bib268","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.dadm.2016.09.001","article-title":"Nonvascular retinal imaging markers of preclinical Alzheimer\u2019s disease","volume":"4","author":"Snyder","year":"2016","journal-title":"Alzheimer\u2019s Dement. (Amst., Neth. )"},{"key":"10.1016\/j.arr.2022.101819_bib269","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib270","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1113\/jphysiol.2007.134502","article-title":"Dopamine and working memory mechanisms in prefrontal cortex","volume":"581","author":"Surmeier","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.arr.2022.101819_bib271","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/jpet.103.050104","article-title":"Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons","volume":"306","author":"Takada","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib272","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.neuroimage.2015.08.050","article-title":"The human hippocampus is not sexually-dimorphic: Meta-analysis of structural MRI volumes","volume":"124","author":"Tan","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2022.101819_bib273","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2133\/dmpk.DMPK-11-RV-121","article-title":"Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance","volume":"27","author":"Teh","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.arr.2022.101819_bib274","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/ene.15270","article-title":"Antemortem basal forebrain atrophy in pure limbic TAR DNA\u2010binding protein 43 pathology compared with pure Alzheimer pathology","volume":"29","author":"Teipel","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib275","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hbm.21111","article-title":"The cholinergic system in mild cognitive impairment and Alzheimer\u2019s disease: an in vivo MRI and DTI study","volume":"32","author":"Teipel","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2022.101819_bib276","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fneur.2018.00642","article-title":"Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer\u2019s Disease Treated With Cholinesterase Inhibitors","volume":"9","author":"Teipel","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib277","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3233\/JAD-215196","article-title":"Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer\u2019s Disease Spectrum","volume":"85","author":"Teipel","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101819_bib278","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-018-0014-y","article-title":"Cerebral small vessel disease: from a focal to a global perspective","volume":"14","author":"Ter Telgte","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib279","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/157015908785777247","article-title":"Role of the Central Cholinergic System in the Therapeutics of Schizophrenia","volume":"6","author":"Terry","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib280","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.bjp.0706221","article-title":"Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity","volume":"145","author":"Texid\u00f3","year":"2005","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.arr.2022.101819_bib281","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000275674","article-title":"Treatment effects of therapeutic cholinesterase inhibitors on visuospatial processing in Alzheimer\u2019s disease: a longitudinal functional MRI study","volume":"29","author":"Thiyagesh","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib282","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.54.2.407","article-title":"Cholinergic dysfunction in diseases with Lewy bodies","volume":"54","author":"Tiraboschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101819_bib283","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801\u2014the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib284","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jgs.15069","article-title":"Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer\u2019s Disease: Systematic Review and Network Metaanalysis","volume":"66","author":"Tricco","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2022.101819_bib285","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1096\/fj.201900444R","article-title":"Low availability of choline in utero disrupts development and function of the retina","volume":"33","author":"Trujillo-Gonzalez","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2022.101819_bib286","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbr.2009.12.047","article-title":"The cerebrovascular role of the cholinergic neural system in Alzheimer\u2019s disease","volume":"221","author":"Van Beek","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2022.101819_bib287","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jalz.2019.07.001","article-title":"Brain A\u03b2 load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2022.101819_bib288","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/alz.12228","article-title":"Plasma \u03b2-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD","volume":"17","author":"Vergallo","year":"2021","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.arr.2022.101819_bib289","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib290","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/arclin\/acy032","article-title":"Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer\u2019s Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial","volume":"34","author":"Vila-Castelar","year":"2019","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.arr.2022.101819_bib291","article-title":"Visual-stimuli Four-arm Maze test to Assess Cognition and Vision in Mice","volume":"11","author":"Vit","year":"2021","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.arr.2022.101819_bib292","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41598-021-80988-0","article-title":"Color and contrast vision in mouse models of aging and Alzheimer\u2019s disease using a novel visual-stimuli four-arm maze","volume":"11","author":"Vit","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101819_bib293","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acschemneuro.8b00391","article-title":"Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer\u2019s Disease","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2022.101819_bib294","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0028-3908(99)00157-4","article-title":"Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats","volume":"39","author":"Wang","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2022.101819_bib295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(01)01498-4","article-title":"Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine","volume":"433","author":"Wang","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2022.101819_bib296","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib297","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JAD-142589","article-title":"APOE-\u025b4 Carrier Status and Donepezil Response in Patients with Alzheimer\u2019s Disease","volume":"47","author":"Waring","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101819_bib298","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WAD.0b013e3181f5dd97","article-title":"Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment","volume":"25","author":"Wattmo","year":"2011","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib299","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/alzrt85","article-title":"Predictors of long-term cognitive outcome in Alzheimer\u2019s disease","volume":"3","author":"Wattmo","year":"2011","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2022.101819_bib300","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000362926","article-title":"Risk factors that affect life expectancy in Alzheimer\u2019s disease: a 15-year follow-up","volume":"38","author":"Wattmo","year":"2014","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib301","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000437050","article-title":"Longitudinal Associations between Survival in Alzheimer\u2019s Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services","volume":"40","author":"Wattmo","year":"2015","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2022.101819_bib302","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/EB.S9902","article-title":"Differential effects of amyloid-\u03b2 peptide aggregation status on in vivo retinal neurotoxicity","volume":"2","author":"Watts","year":"2010","journal-title":"Eye Brain"},{"key":"10.1016\/j.arr.2022.101819_bib303","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41467-019-10219-8","article-title":"Cholinergic neural activity directs retinal layer-specific angiogenesis and blood retinal barrier formation","volume":"10","author":"Weiner","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2022.101819_bib304","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3233\/JAD-150152","article-title":"Acute Effects of Muscarinic M1 Receptor Modulation on A\u03b2PP Metabolism and Amyloid-\u03b2 Levels in vivo: A Microdialysis Study","volume":"46","author":"Welt","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2022.101819_bib305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084059","article-title":"CHRNA7 Polymorphisms and Response to Cholinesterase Inhibitors in Alzheimer\u2019s Disease","volume":"8","author":"Weng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2022.101819_bib306","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410130304","article-title":"Basal forebrain neurons in the dementia of Parkinson disease","volume":"13","author":"Whitehouse","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib307","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/hbm.25572","article-title":"Neuroanatomical norms in the UK Biobank: The impact of allometric scaling, sex, and age","volume":"42","author":"Williams","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2022.101819_bib308","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-12-819975-6.00010-8","article-title":"Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson\u2019s disease","volume":"179","author":"Wilson","year":"2021","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib309","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1212\/WNL.57.3.489","article-title":"A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD","volume":"57","author":"Winblad","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101819_bib310","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10548-017-0608-5","article-title":"Brain networks are independently modulated by donepezil, sleep, and sleep deprivation","volume":"31","author":"Wirsich","year":"2018","journal-title":"Brain Topogr."},{"key":"10.1016\/j.arr.2022.101819_bib311","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40263-016-0356-1","article-title":"Effect of the CYP2D6 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"30","author":"Xiao","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2022.101819_bib312","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","article-title":"M\u00fcller cell degeneration and microglial dysfunction in the Alzheimer\u2019s retina","volume":"10","author":"Xu","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2022.101819_bib313","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.25707","article-title":"Dopaminergic depletion, \u03b2-amyloid burden, and cognition in lewy body disease","volume":"87","author":"Yoo","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2022.101819_bib314","doi-asserted-by":"crossref","first-page":"e947","DOI":"10.1212\/WNL.0000000000013277","article-title":"Association of \u03b2-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra","volume":"98","author":"Yoo","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101819_bib315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0035-1545300","article-title":"Association of the choline acetyltransferase gene with responsiveness to acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"48","author":"Yoon","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.arr.2022.101819_bib316","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2004.12.004","article-title":"Donepezil blocks voltage-gated ion channels in rat dissociated hippocampal neurons","volume":"508","author":"Yu","year":"2005","journal-title":"Eur. J. Pharmacol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722002616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722002616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:03:54Z","timestamp":1761591834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163722002616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":316,"alternative-id":["S1568163722002616"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2022.101819","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer\u2019s disease: relevance for precision medicine in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2022.101819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101819"}}